Bionik Laboratories Corp. Quarterly Depreciation in USD from Q1 2014 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
The amount of expense recognized in the current period that reflects the allocation of the cost of tangible assets over the assets' useful lives. Includes production and non-production related depreciation.
Summary
Bionik Laboratories Corp. quarterly/annual Depreciation history and growth rate from Q1 2014 to Q1 2023.
  • Bionik Laboratories Corp. Depreciation for the quarter ending March 31, 2023 was $18K, a 100% increase year-over-year.
  • Bionik Laboratories Corp. Depreciation for the twelve months ending March 31, 2023 was $61K, a 52.5% increase year-over-year.
  • Bionik Laboratories Corp. annual Depreciation for 2022 was $61K, a 52.5% increase from 2021.
  • Bionik Laboratories Corp. annual Depreciation for 2021 was $40K, a 31% decline from 2020.
  • Bionik Laboratories Corp. annual Depreciation for 2020 was $58K, a 42% decline from 2019.
Depreciation, Trailing 12 Months (USD)
Depreciation, Quarterly (USD)
Depreciation, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $61K $18K +$9K +100% Jan 1, 2023 Mar 31, 2023 10-K 2023-06-21
Q4 2022 $52K $19K +$8K +72.7% Oct 1, 2022 Dec 31, 2022 10-Q 2023-02-08
Q3 2022 $44K $12K +$1K +9.09% Jul 1, 2022 Sep 30, 2022 10-Q 2022-11-09
Q2 2022 $43K $12K +$3K +33.3% Apr 1, 2022 Jun 30, 2022 10-Q 2022-08-10
Q1 2022 $40K $9K $0 0% Jan 1, 2022 Mar 31, 2022 10-K 2023-06-21
Q4 2021 $40K $11K -$4K -26.7% Oct 1, 2021 Dec 31, 2021 10-Q 2023-02-08
Q3 2021 $44K $11K -$5K -31.3% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-09
Q2 2021 $49K $9K -$9K -50% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-10
Q1 2021 $58K $9K -$12K -57.1% Jan 1, 2021 Mar 31, 2021 10-K 2022-06-09
Q4 2020 $70K $15K -$13K -46.4% Oct 1, 2020 Dec 31, 2020 10-Q 2022-02-09
Q3 2020 $83K $16K -$11.1K -40.9% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-10
Q2 2020 $94K $18K -$5.97K -24.9% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-12
Q1 2020 $100K $21K +$1.95K +10.2% Jan 1, 2020 Mar 31, 2020 10-K 2021-06-24
Q4 2019 $98.1K $28K +$12K +75.3% Oct 1, 2019 Dec 31, 2019 10-Q 2021-02-11
Q3 2019 $86K $27.1K +$10.4K +62.8% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-12
Q2 2019 $75.6K $24K +$6.38K +36.2% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-12
Q1 2019 $69.2K $19K -$398 -2.05% Jan 1, 2019 Mar 31, 2019 10-K 2020-06-30
Q4 2018 $69.6K $16K -$5.27K -24.8% Oct 1, 2018 Dec 31, 2018 10-Q 2020-02-14
Q3 2018 $74.9K $16.6K -$7.19K -30.2% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-14
Q2 2018 $82.1K $17.6K -$6.96K -28.3% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-12
Q1 2018 $89K $19.4K -$2.67K -12.1% Jan 1, 2018 Mar 31, 2018 10-K 2019-07-01
Q4 2017 $91.7K $21.2K -$2.79K -11.6% Oct 1, 2017 Dec 31, 2017 10-Q 2019-02-11
Q3 2017 $94.5K $23.8K +$230 +0.98% Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-13
Q2 2017 $94.3K $24.6K +$14.4K +142% Apr 1, 2017 Jun 30, 2017 10-Q 2018-08-14
Q1 2017 $79.9K $22.1K +$7.7K +53.5% Jan 1, 2017 Mar 31, 2017 10-K 2018-06-27
Q4 2016 $72.2K $24K +$3.15K +15.1% Oct 1, 2016 Dec 31, 2016 10-Q 2018-02-13
Q3 2016 $69K $23.6K +$8.11K +52.4% Jul 1, 2016 Sep 30, 2016 10-Q 2017-11-13
Q2 2016 $60.9K $10.2K -$6.84K -40.2% Apr 1, 2016 Jun 30, 2016 10-Q 2017-08-14
Q1 2016 $67.7K $14.4K +$3.98K +38.2% Jan 1, 2016 Mar 31, 2016 10-KT 2016-06-30
Q4 2015 $63.8K $20.9K Oct 1, 2015 Dec 31, 2015 10-Q 2017-02-14
Q3 2015 $15.5K +$4.05K +35.5% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-15
Q2 2015 $17K +$5.51K +47.9% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-15
Q1 2015 $10.4K +$9.99K +2361% Jan 1, 2015 Mar 31, 2015 10-KT 2016-06-30
Q3 2014 $11.4K Jul 1, 2014 Sep 30, 2014 10-Q/A 2016-03-17
Q2 2014 $11.5K Apr 1, 2014 Jun 30, 2014 10-Q/A 2016-03-17
Q1 2014 $423 Jan 1, 2014 Mar 31, 2014 10-Q/A 2016-03-17
* An asterisk sign (*) next to the value indicates that the value is likely invalid.